Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Incyte Corp INCY

Healthcare Biotechnology
Incyte Corporation is a biopharmaceutical company, which is focused on the discovery, development, and commercialization of therapeutics. The Company also conducts clinical development and commercial operations from its European headquarters in Morges, Switzerland and its other offices across Europe, as well as its Japanese office in Tokyo and its Canadian headquarters in Montreal. It operates... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:INCY)

Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists

Business Wire 1 day ago

Incyte to Report First Quarter Financial Results

Business Wire 13 days ago

Incyte and CMS Announce Collaboration and License Agreement for Povorcitinib, an Oral JAK1 Inhibitor, in Mainland China, Hong Kong, Macau, Taiwan and Southeast Asia

Business Wire April 1, 2024

Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Business Wire March 29, 2024

Incyte Presents New Late-Breaking Data from Phase 2 Study Evaluating Povorcitinib in Patients with Prurigo Nodularis

Business Wire March 10, 2024

Incyte Announces New Data from Phase 2 Study Evaluating Ruxolitinib Cream (Opzelura®) in Patients with Mild-to-Moderate Hidradenitis Suppurativa

Business Wire March 10, 2024

New Data from Incyte's Growing Dermatology Portfolio to be Presented at the 2024 American Academy of Dermatology (AAD) Annual Meeting

Business Wire March 4, 2024

Incyte Launches The Unseen Journey to Elevate the Hidden Impact of Myeloproliferative Neoplasms (MPNs) on Patients' Lives through Generative AI

Business Wire February 29, 2024

Knight Therapeutics Announces Launch of Minjuvi® in Brazil

GlobeNewswire February 29, 2024
View More News ››

Opinion & Analysis (NDAQ:INCY)

Immuno-Oncology candidate yields 'impressive' early clinical results

Streetwise Reports December 7, 2017

3 Biotech ETFs Rally On Merger News

Benzinga.com  December 8, 2014

Stock picks that include a couple of Canadian miners

J.W. Cotton June 26, 2009
View More Opinion ››

Bullboard Posts (NDAQ:INCY)

INCY / INCYTE corporation - A good Investment option

<< View Post To Watch Video >>
flyjeetu - May 26, 2021

Take a look at Theralase vtlt

They may hold the cure for bladder cancer as well as brain and lung cancer In clinical trial for bladder cancer looking very good .This...
goregil - February 12, 2019

Buy rating and $19 price

Piper Jaffray adds Incyte Corp. to its Alpha List, citing a positive data release on Incyte's lead JAK2 inhibitor at the European...
mart33 - April 8, 2008

news/ratings ta

NEW YORK, February 18 - Analysts at UBS maintain their "buy" rating on Incyte Corp  while reducing their estimates for the...
mart33 - March 24, 2008

Incyte Reports 47% UP ( INCY : Nasdaq)

10/17/00 - Incyte Reports 47% Year-to-year Increase in Third Quarter Revenue PALO ALTO, Calif., Oct. 17 /PRNewswire/ -- Incyte...
Nano2000 - October 18, 2000

Nice,in at 31.25,today reached up to 71

before settling at 47....GOOD NEWS:discovery of a gene related with diabetes type 2.
NeedaQuarterMill - December 22, 1999
View more Bullboard ››

Canada Jetlines Operations Ltd

Canada Jetlines Operations Ltd

Canada Jetlines Operations Ltd. is a Canada-based leisure-focused air carrier. The Company's principal business activities ...
View More »